What is Augmedics?
Augmedics is at the forefront of augmented reality (AR) innovation within the surgical domain. The company is dedicated to improving patient outcomes and operational efficiency by integrating advanced AR technologies into surgical procedures. By addressing unmet clinical needs and bolstering the confidence of surgical teams, Augmedics is reshaping the future of surgery. Their solutions aim to provide real-time, data-driven insights directly within the surgeon's field of view, thereby enhancing precision and decision-making during complex operations.
How much funding has Augmedics raised?
Augmedics has raised a total of $141.8M across 4 funding rounds:
Series A
$8.3M
Series B
$15M
Unspecified
$36M
Series D
$82.5M
Series A (2017): $8.3M with participation from AO Invest and Terra Venture Partners
Series B (2020): $15M, investors not publicly disclosed
Unspecified (2021): $36M supported by H.I.G. Capital, Revival Healthcare Capital, Hospital Corporation of America, Almeda Ventures, and XR Investment
Series D (2023): $82.5M featuring Cpmg, Revival Healthcare Capital, H.I.G. Capital, and Almeda Ventures
Key Investors in Augmedics
H.I.G. Capital
H.I.G. Capital is a prominent global alternative investment firm specializing in the mid-cap market. They leverage their extensive platform to create long-term value across various strategies, including private equity, growth equity, and healthcare-focused investments.
Almeda Ventures
Almeda Ventures is a unique HealthTech-focused public R&D partnership that invests globally in medical devices and digital health. They aim to foster the success of innovative healthcare companies by providing capital and leveraging their extensive industry network and expertise.
Revival Healthcare Capital
Revival Healthcare Capital, established in 2018, is an Austin-based firm dedicated to providing its partners with essential tools and strategic advice to optimize capital potential within the healthcare sector.
What's next for Augmedics?
With the recent influx of major strategic investment, Augmedics is poised for significant expansion and further technological development. This capital infusion will likely fuel the scaling of its operations, enabling broader market penetration and the enhancement of its AR surgical guidance platform. The company's focus on solving critical clinical challenges suggests a strategic direction towards solidifying its position as a leader in surgical innovation, potentially exploring new applications and partnerships to further its impact on global healthcare.
See full Augmedics company page
